Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Tamoxifen caused hair loss in a 52-year-old woman.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Breast cancer may be detectable through changes in scalp hair lipids.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The document explains breast development, common breast conditions, and their treatments.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Spironolactone does not increase the risk of breast cancer recurrence.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Some breast cancer chemotherapy can cause permanent hair loss.